Drug recall · September 2, 2020
Sulfamethoxazole and Trimethoprim Tablets recall
Why: Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s).
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sulfamethoxazole and Trimethoprim Tablets, USP, 800 mg/160 mg Double Strength, 500 Tablets per bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC: 65862-420-05.
- Lots / codes
Lot #s: STSD19109-A, Exp. 05/31/2022; SP1D19083AA3, SP1D19084AA3, Exp. 08/31/2022.
- Quantity
- 5748 bottles
- Company
- Aurobindo Pharma USA Inc., East Windsor, NJ
- Distribution
- Nationwide in the U.S.
- Initiated
- August 10, 2020 · Voluntary: Firm initiated
- Classified
- August 21, 2020
- Reported
- September 2, 2020
- Ended
- June 28, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sulfamethoxazole / trimethoprim
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.